Amalia A. van Everdingen

866 total citations
10 papers, 615 citations indexed

About

Amalia A. van Everdingen is a scholar working on Rheumatology, Neurology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Amalia A. van Everdingen has authored 10 papers receiving a total of 615 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Rheumatology, 3 papers in Neurology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Amalia A. van Everdingen's work include Rheumatoid Arthritis Research and Therapies (10 papers), Systemic Lupus Erythematosus Research (8 papers) and Peripheral Neuropathies and Disorders (3 papers). Amalia A. van Everdingen is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (10 papers), Systemic Lupus Erythematosus Research (8 papers) and Peripheral Neuropathies and Disorders (3 papers). Amalia A. van Everdingen collaborates with scholars based in Netherlands. Amalia A. van Everdingen's co-authors include J. W. J. Bijlsma, Johannes W. G. Jacobs, Suzanne Verstappen, Johannes W G Jacobs, H. R. Van Den Brink, Willem F. Lems, J. W. G. Jacobs, Margriet Huisman, Jos N. Hoes and M. J. G. Wenting and has published in prestigious journals such as Annals of Internal Medicine, Annals of the New York Academy of Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Amalia A. van Everdingen

10 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amalia A. van Everdingen Netherlands 10 475 110 77 75 75 10 615
Tarek Carlos Salman-Monte Spain 10 262 0.6× 36 0.3× 25 0.3× 18 0.2× 15 0.2× 49 337
Vera Golder Australia 14 437 0.9× 44 0.4× 9 0.1× 43 0.6× 16 0.2× 24 516
Phil Perkins United Kingdom 5 238 0.5× 69 0.6× 7 0.1× 37 0.5× 25 0.3× 11 482
Joy Feld Israel 17 663 1.4× 276 2.5× 12 0.2× 38 0.5× 44 0.6× 42 854
Kazunori Nagai Japan 12 51 0.1× 127 1.2× 65 0.8× 121 1.6× 12 0.2× 32 536
Michela Gasparotto Italy 9 164 0.3× 40 0.4× 42 0.5× 7 0.1× 7 0.1× 20 401
Marie Godfrin-Valnet France 12 322 0.7× 81 0.7× 6 0.1× 29 0.4× 27 0.4× 21 433
P.V. Voulgari Greece 12 279 0.6× 92 0.8× 17 0.2× 27 0.4× 16 0.2× 29 539
D E Carey United States 6 165 0.3× 19 0.2× 41 0.5× 51 0.7× 35 0.5× 9 334
Niels Borgstein United States 12 89 0.2× 88 0.8× 54 0.7× 75 1.0× 16 0.2× 21 594

Countries citing papers authored by Amalia A. van Everdingen

Since Specialization
Citations

This map shows the geographic impact of Amalia A. van Everdingen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amalia A. van Everdingen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amalia A. van Everdingen more than expected).

Fields of papers citing papers by Amalia A. van Everdingen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amalia A. van Everdingen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amalia A. van Everdingen. The network helps show where Amalia A. van Everdingen may publish in the future.

Co-authorship network of co-authors of Amalia A. van Everdingen

This figure shows the co-authorship network connecting the top 25 collaborators of Amalia A. van Everdingen. A scholar is included among the top collaborators of Amalia A. van Everdingen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amalia A. van Everdingen. Amalia A. van Everdingen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bijlsma, J. W. J., Jos N. Hoes, Amalia A. van Everdingen, Suzanne Verstappen, & Johannes W. G. Jacobs. (2006). Are Glucocorticoids DMARDs?. Annals of the New York Academy of Sciences. 1069(1). 268–274. 26 indexed citations
2.
Jacobs, Johannes W. G., Amalia A. van Everdingen, Suzanne Verstappen, & J. W. J. Bijlsma. (2006). Followup radiographic data on patients with rheumatoid arthritis who participated in a two‐year trial of prednisone therapy or placebo. Arthritis & Rheumatism. 54(5). 1422–1428. 57 indexed citations
3.
Everdingen, Amalia A. van, et al.. (2004). The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies. Arthritis Care & Research. 51(2). 233–238. 23 indexed citations
4.
Everdingen, Amalia A. van, et al.. (2003). Low-dose glucocorticoids in early rheumatoid arthritis: discordant effects on bone mineral density and fractures?. PubMed. 21(2). 155–60. 42 indexed citations
5.
Bijlsma, J. W. J., et al.. (2002). Glucocorticoids in Rheumatoid Arthritis. Annals of the New York Academy of Sciences. 966(1). 82–90. 29 indexed citations
7.
Huisman, A.M., Amalia A. van Everdingen, M. J. G. Wenting, et al.. (2002). Glucocorticoid Receptor Downregulation in Early Diagnosed Rheumatoid Arthritis. Annals of the New York Academy of Sciences. 966(1). 64–67. 12 indexed citations
8.
Bijlsma, J. W. J., Amalia A. van Everdingen, & Johannes W. G. Jacobs. (1995). Corticosteroids in Rheumatoid Arthritis. Clinical Immunotherapeutics. 3(4). 271–286. 13 indexed citations
9.
Brink, H. R. Van Den, Willem F. Lems, Amalia A. van Everdingen, & J. W. J. Bijlsma. (1993). Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis.. Annals of the Rheumatic Diseases. 52(4). 302–305. 32 indexed citations
10.
Brink, H. R. Van Den, et al.. (1993). Adjuvant oestrogen therapy does not improve disease activity in postmenopausal patients with rheumatoid arthritis.. Annals of the Rheumatic Diseases. 52(12). 862–865. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026